0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Calcium Antagonists Sales Market Report 2021
Published Date: June 2021
|
Report Code: QYRE-Auto-21P5222
Home | Market Reports | Health | Health Conditions | Heart & Hypertension
Global Calcium Antagonists Sales Market Report 2021

Global Calcium Antagonists Sales Market Report 2021

Code: QYRE-Auto-21P5222
Report
June 2021
148 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.
CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.
Market Analysis and Insights: Global Calcium Antagonists Market
The global Calcium Antagonists market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Calcium Antagonists Scope and Market Size
The global Calcium Antagonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Calcium Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

Dihydropyridine
Diltiazem
Verapamil
Others

Segment by Application

Hypertension
Coronary Artery Disease
Arrhythmia
Ohers
The Calcium Antagonists market is analysed and market size information is provided by regions (countries). Segment by Application, the Calcium Antagonists market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

BY COMPANY

Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku
1 Calcium Antagonists Market Overview
1.1 Calcium Antagonists Product Scope
1.2 Calcium Antagonists Segment by Type
1.2.1 Global Calcium Antagonists Sales by Type (2016 & 2021 & 2027)
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Calcium Antagonists Segment by Application
1.3.1 Global Calcium Antagonists Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Ohers
1.4 Calcium Antagonists Market Estimates and Forecasts (2016-2027)
1.4.1 Global Calcium Antagonists Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Calcium Antagonists Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Calcium Antagonists Price Trends (2016-2027)
2 Calcium Antagonists Estimates and Forecasts by Region
2.1 Global Calcium Antagonists Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Calcium Antagonists Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Calcium Antagonists Sales Market Share by Region (2016-2021)
2.2.2 Global Calcium Antagonists Revenue Market Share by Region (2016-2021)
2.3 Global Calcium Antagonists Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Calcium Antagonists Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Calcium Antagonists Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Calcium Antagonists Estimates and Projections (2016-2027)
2.4.2 Europe Calcium Antagonists Estimates and Projections (2016-2027)
2.4.3 China Calcium Antagonists Estimates and Projections (2016-2027)
2.4.4 Japan Calcium Antagonists Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Calcium Antagonists Estimates and Projections (2016-2027)
2.4.6 India Calcium Antagonists Estimates and Projections (2016-2027)
3 Global Calcium Antagonists Competition Landscape by Players
3.1 Global Top Calcium Antagonists Players by Sales (2016-2021)
3.2 Global Top Calcium Antagonists Players by Revenue (2016-2021)
3.3 Global Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2020)
3.4 Global Calcium Antagonists Average Price by Company (2016-2021)
3.5 Manufacturers Calcium Antagonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Calcium Antagonists Market Size by Type
4.1 Global Calcium Antagonists Historic Market Review by Type (2016-2021)
4.1.1 Global Calcium Antagonists Sales Market Share by Type (2016-2021)
4.1.2 Global Calcium Antagonists Revenue Market Share by Type (2016-2021)
4.1.3 Global Calcium Antagonists Price by Type (2016-2021)
4.2 Global Calcium Antagonists Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Calcium Antagonists Sales Forecast by Type (2022-2027)
4.2.2 Global Calcium Antagonists Revenue Forecast by Type (2022-2027)
4.2.3 Global Calcium Antagonists Price Forecast by Type (2022-2027)
5 Global Calcium Antagonists Market Size by Application
5.1 Global Calcium Antagonists Historic Market Review by Application (2016-2021)
5.1.1 Global Calcium Antagonists Sales Market Share by Application (2016-2021)
5.1.2 Global Calcium Antagonists Revenue Market Share by Application (2016-2021)
5.1.3 Global Calcium Antagonists Price by Application (2016-2021)
5.2 Global Calcium Antagonists Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Calcium Antagonists Sales Forecast by Application (2022-2027)
5.2.2 Global Calcium Antagonists Revenue Forecast by Application (2022-2027)
5.2.3 Global Calcium Antagonists Price Forecast by Application (2022-2027)
6 North America Calcium Antagonists Market Facts & Figures
6.1 North America Calcium Antagonists Sales by Company
6.1.1 North America Calcium Antagonists Sales by Company (2016-2021)
6.1.2 North America Calcium Antagonists Revenue by Company (2016-2021)
6.2 North America Calcium Antagonists Sales Breakdown by Type
6.2.1 North America Calcium Antagonists Sales Breakdown by Type (2016-2021)
6.2.2 North America Calcium Antagonists Sales Breakdown by Type (2022-2027)
6.3 North America Calcium Antagonists Sales Breakdown by Application
6.3.1 North America Calcium Antagonists Sales Breakdown by Application (2016-2021)
6.3.2 North America Calcium Antagonists Sales Breakdown by Application (2022-2027)
7 Europe Calcium Antagonists Market Facts & Figures
7.1 Europe Calcium Antagonists Sales by Company
7.1.1 Europe Calcium Antagonists Sales by Company (2016-2021)
7.1.2 Europe Calcium Antagonists Revenue by Company (2016-2021)
7.2 Europe Calcium Antagonists Sales Breakdown by Type
7.2.1 Europe Calcium Antagonists Sales Breakdown by Type (2016-2021)
7.2.2 Europe Calcium Antagonists Sales Breakdown by Type (2022-2027)
7.3 Europe Calcium Antagonists Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Calcium Antagonists Market Facts & Figures
8.1 China Calcium Antagonists Sales by Company
8.1.1 China Calcium Antagonists Sales by Company (2016-2021)
8.1.2 China Calcium Antagonists Revenue by Company (2016-2021)
8.2 China Calcium Antagonists Sales Breakdown by Type
8.2.1 China Calcium Antagonists Sales Breakdown by Type (2016-2021)
8.2.2 China Calcium Antagonists Sales Breakdown by Type (2022-2027)
8.3 China Calcium Antagonists Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Calcium Antagonists Market Facts & Figures
9.1 Japan Calcium Antagonists Sales by Company
9.1.1 Japan Calcium Antagonists Sales by Company (2016-2021)
9.1.2 Japan Calcium Antagonists Revenue by Company (2016-2021)
9.2 Japan Calcium Antagonists Sales Breakdown by Type
9.2.1 Japan Calcium Antagonists Sales Breakdown by Type (2016-2021)
9.2.2 Japan Calcium Antagonists Sales Breakdown by Type (2022-2027)
9.3 Japan Calcium Antagonists Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Calcium Antagonists Market Facts & Figures
10.1 Southeast Asia Calcium Antagonists Sales by Company
10.1.1 Southeast Asia Calcium Antagonists Sales by Company (2016-2021)
10.1.2 Southeast Asia Calcium Antagonists Revenue by Company (2016-2021)
10.2 Southeast Asia Calcium Antagonists Sales Breakdown by Type
10.2.1 Southeast Asia Calcium Antagonists Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Calcium Antagonists Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Calcium Antagonists Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Calcium Antagonists Market Facts & Figures
11.1 India Calcium Antagonists Sales by Company
11.1.1 India Calcium Antagonists Sales by Company (2016-2021)
11.1.2 India Calcium Antagonists Revenue by Company (2016-2021)
11.2 India Calcium Antagonists Sales Breakdown by Type
11.2.1 India Calcium Antagonists Sales Breakdown by Type (2016-2021)
11.2.2 India Calcium Antagonists Sales Breakdown by Type (2022-2027)
11.3 India Calcium Antagonists Sales Breakdown by Application
11.3.1 India Calcium Antagonists Sales Breakdown by Application (2016-2021)
11.3.2 India Calcium Antagonists Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Calcium Antagonists Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Calcium Antagonists Products Offered
12.1.5 Pfizer Recent Development
12.2 Aventis
12.2.1 Aventis Corporation Information
12.2.2 Aventis Business Overview
12.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Aventis Calcium Antagonists Products Offered
12.2.5 Aventis Recent Development
12.3 Searle
12.3.1 Searle Corporation Information
12.3.2 Searle Business Overview
12.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Searle Calcium Antagonists Products Offered
12.3.5 Searle Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Calcium Antagonists Products Offered
12.4.5 Bayer Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Business Overview
12.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Calcium Antagonists Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Knoll Pharmaceuticals
12.6.1 Knoll Pharmaceuticals Corporation Information
12.6.2 Knoll Pharmaceuticals Business Overview
12.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Knoll Pharmaceuticals Calcium Antagonists Products Offered
12.6.5 Knoll Pharmaceuticals Recent Development
12.7 Wyeth-Ayerst
12.7.1 Wyeth-Ayerst Corporation Information
12.7.2 Wyeth-Ayerst Business Overview
12.7.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Wyeth-Ayerst Calcium Antagonists Products Offered
12.7.5 Wyeth-Ayerst Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Business Overview
12.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Calcium Antagonists Products Offered
12.8.5 Novartis Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Business Overview
12.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Calcium Antagonists Products Offered
12.9.5 Sanofi Recent Development
12.10 Baiyunshan Pharmaceutical
12.10.1 Baiyunshan Pharmaceutical Corporation Information
12.10.2 Baiyunshan Pharmaceutical Business Overview
12.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Products Offered
12.10.5 Baiyunshan Pharmaceutical Recent Development
12.11 South China Pharmaceutical Group
12.11.1 South China Pharmaceutical Group Corporation Information
12.11.2 South China Pharmaceutical Group Business Overview
12.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.11.4 South China Pharmaceutical Group Calcium Antagonists Products Offered
12.11.5 South China Pharmaceutical Group Recent Development
12.12 Tianjin Tanabe Seiyaku
12.12.1 Tianjin Tanabe Seiyaku Corporation Information
12.12.2 Tianjin Tanabe Seiyaku Business Overview
12.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Products Offered
12.12.5 Tianjin Tanabe Seiyaku Recent Development
13 Calcium Antagonists Manufacturing Cost Analysis
13.1 Calcium Antagonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Calcium Antagonists
13.4 Calcium Antagonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Calcium Antagonists Distributors List
14.3 Calcium Antagonists Customers
15 Market Dynamics
15.1 Calcium Antagonists Market Trends
15.2 Calcium Antagonists Drivers
15.3 Calcium Antagonists Market Challenges
15.4 Calcium Antagonists Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Calcium Antagonists Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Calcium Antagonists Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Calcium Antagonists Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Calcium Antagonists Sales (K Units) by Region (2016-2021)
    Table 5. Global Calcium Antagonists Sales Market Share by Region (2016-2021)
    Table 6. Global Calcium Antagonists Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Calcium Antagonists Revenue Share by Region (2016-2021)
    Table 8. Global Calcium Antagonists Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Calcium Antagonists Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Calcium Antagonists Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Calcium Antagonists Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Calcium Antagonists Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Calcium Antagonists Sales Share by Company (2016-2021)
    Table 14. Global Calcium Antagonists Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Calcium Antagonists Revenue Share by Company (2016-2021)
    Table 16. Global Calcium Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Antagonists as of 2020)
    Table 17. Global Calcium Antagonists Average Price (USD/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Calcium Antagonists Manufacturing Sites and Area Served
    Table 19. Manufacturers Calcium Antagonists Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Calcium Antagonists Sales (K Units) by Type (2016-2021)
    Table 22. Global Calcium Antagonists Sales Share by Type (2016-2021)
    Table 23. Global Calcium Antagonists Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Calcium Antagonists Price (USD/Unit) by Type (2016-2021)
    Table 25. Global Calcium Antagonists Sales Share by Type (2022-2027)
    Table 26. Global Calcium Antagonists Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 27. Global Calcium Antagonists Revenue Share by Type (2022-2027)
    Table 28. Global Calcium Antagonists Price (USD/Unit) by Type (2022-2027)
    Table 29. Global Calcium Antagonists Sales (K Units) by Application (2016-2021)
    Table 30. Global Calcium Antagonists Sales Share by Application (2016-2021)
    Table 31. Global Calcium Antagonists Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Calcium Antagonists Price (USD/Unit) by Application (2016-2021)
    Table 33. Global Calcium Antagonists Sales (K Units) by Application (2022-2027)
    Table 34. Global Calcium Antagonists Sales Share by Application (2022-2027)
    Table 35. Global Calcium Antagonists Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Calcium Antagonists Revenue Share by Application (2022-2027)
    Table 37. Global Calcium Antagonists Price (USD/Unit) by Application (2022-2027)
    Table 38. North America Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 39. North America Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 40. North America Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 42. North America Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 43. North America Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 44. North America Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 45. North America Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 46. North America Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 47. North America Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 48. North America Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 49. North America Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 50. Europe Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 51. Europe Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 52. Europe Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 54. Europe Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 56. Europe Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 58. Europe Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 60. Europe Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 62. China Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 63. China Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 64. China Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 66. China Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 67. China Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 68. China Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 69. China Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 70. China Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 71. China Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 72. China Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 73. China Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 74. Japan Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 75. Japan Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 76. Japan Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 78. Japan Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 80. Japan Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 82. Japan Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 84. Japan Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 98. India Calcium Antagonists Sales (K Units) by Company (2016-2021)
    Table 99. India Calcium Antagonists Sales Market Share by Company (2016-2021)
    Table 100. India Calcium Antagonists Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Calcium Antagonists Revenue Market Share by Company (2016-2021)
    Table 102. India Calcium Antagonists Sales by Type (2016-2021) & (K Units)
    Table 103. India Calcium Antagonists Sales Market Share by Type (2016-2021)
    Table 104. India Calcium Antagonists Sales by Type (2022-2027) & (K Units)
    Table 105. India Calcium Antagonists Sales Market Share by Type (2022-2027)
    Table 106. India Calcium Antagonists Sales by Application (2016-2021) & (K Units)
    Table 107. India Calcium Antagonists Sales Market Share by Application (2016-2021)
    Table 108. India Calcium Antagonists Sales by Application (2022-2027) & (K Units)
    Table 109. India Calcium Antagonists Sales Market Share by Application (2022-2027)
    Table 110. Pfizer Corporation Information
    Table 111. Pfizer Description and Business Overview
    Table 112. Pfizer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. Pfizer Calcium Antagonists Product
    Table 114. Pfizer Recent Development
    Table 115. Aventis Corporation Information
    Table 116. Aventis Description and Business Overview
    Table 117. Aventis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Aventis Calcium Antagonists Product
    Table 119. Aventis Recent Development
    Table 120. Searle Corporation Information
    Table 121. Searle Description and Business Overview
    Table 122. Searle Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Searle Calcium Antagonists Product
    Table 124. Searle Recent Development
    Table 125. Bayer Corporation Information
    Table 126. Bayer Description and Business Overview
    Table 127. Bayer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Bayer Calcium Antagonists Product
    Table 129. Bayer Recent Development
    Table 130. AstraZeneca Corporation Information
    Table 131. AstraZeneca Description and Business Overview
    Table 132. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. AstraZeneca Calcium Antagonists Product
    Table 134. AstraZeneca Recent Development
    Table 135. Knoll Pharmaceuticals Corporation Information
    Table 136. Knoll Pharmaceuticals Description and Business Overview
    Table 137. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. Knoll Pharmaceuticals Calcium Antagonists Product
    Table 139. Knoll Pharmaceuticals Recent Development
    Table 140. Wyeth-Ayerst Corporation Information
    Table 141. Wyeth-Ayerst Description and Business Overview
    Table 142. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Wyeth-Ayerst Calcium Antagonists Product
    Table 144. Wyeth-Ayerst Recent Development
    Table 145. Novartis Corporation Information
    Table 146. Novartis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 147. Novartis Description and Business Overview
    Table 148. Novartis Calcium Antagonists Product
    Table 149. Novartis Recent Development
    Table 150. Sanofi Corporation Information
    Table 151. Sanofi Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 152. Sanofi Description and Business Overview
    Table 153. Sanofi Calcium Antagonists Product
    Table 154. Sanofi Recent Development
    Table 155. Baiyunshan Pharmaceutical Corporation Information
    Table 156. Baiyunshan Pharmaceutical Description and Business Overview
    Table 157. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Baiyunshan Pharmaceutical Calcium Antagonists Product
    Table 159. Baiyunshan Pharmaceutical Recent Development
    Table 160. South China Pharmaceutical Group Corporation Information
    Table 161. South China Pharmaceutical Group Description and Business Overview
    Table 162. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. South China Pharmaceutical Group Calcium Antagonists Product
    Table 164. South China Pharmaceutical Group Recent Development
    Table 165. Tianjin Tanabe Seiyaku Corporation Information
    Table 166. Tianjin Tanabe Seiyaku Description and Business Overview
    Table 167. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. Tianjin Tanabe Seiyaku Calcium Antagonists Product
    Table 169. Tianjin Tanabe Seiyaku Recent Development
    Table 170. Production Base and Market Concentration Rate of Raw Material
    Table 171. Key Suppliers of Raw Materials
    Table 172. Calcium Antagonists Distributors List
    Table 173. Calcium Antagonists Customers List
    Table 174. Calcium Antagonists Market Trends
    Table 175. Calcium Antagonists Market Drivers
    Table 176. Calcium Antagonists Market Challenges
    Table 177. Calcium Antagonists Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Calcium Antagonists Product Picture
    Figure 2. Global Calcium Antagonists Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Calcium Antagonists Sales Market Share by Application in 2021 & 2027
    Figure 6. Hypertension Examples
    Figure 7. Coronary Artery Disease Examples
    Figure 8. Arrhythmia Examples
    Figure 9. Ohers Examples
    Figure 10. Global Calcium Antagonists Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Calcium Antagonists Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Calcium Antagonists Sales (K Units) Growth Rate (2016-2027)
    Figure 13. Global Calcium Antagonists Price Trends Growth Rate (2016-2027) (USD/Unit)
    Figure 14. Global Calcium Antagonists Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Calcium Antagonists Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Calcium Antagonists Sales (K Units) Growth Rate (2016-2027)
    Figure 18. Europe Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Calcium Antagonists Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Calcium Antagonists Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Calcium Antagonists Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Calcium Antagonists Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Calcium Antagonists Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Calcium Antagonists Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Calcium Antagonists Players Market Share by Revenue in Calcium Antagonists: 2016 & 2020
    Figure 29. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Calcium Antagonists Revenue Share by Type (2016-2021)
    Figure 31. Global Calcium Antagonists Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Calcium Antagonists Revenue Share by Application (2016-2021)
    Figure 33. Global Calcium Antagonists Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Calcium Antagonists Sales Market Share by Type in 2020
    Figure 35. North America Calcium Antagonists Sales Market Share by Application in 2020
    Figure 36. Europe Calcium Antagonists Sales Market Share by Type in 2020
    Figure 37. Europe Calcium Antagonists Sales Market Share by Application in 2020
    Figure 38. China Calcium Antagonists Sales Market Share by Type in 2020
    Figure 39. China Calcium Antagonists Sales Market Share by Application in 2020
    Figure 40. Japan Calcium Antagonists Sales Market Share by Type in 2020
    Figure 41. Japan Calcium Antagonists Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Calcium Antagonists Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Calcium Antagonists Sales Market Share by Application in 2020
    Figure 44. India Calcium Antagonists Sales Market Share by Type in 2020
    Figure 45. India Calcium Antagonists Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Calcium Antagonists
    Figure 48. Manufacturing Process Analysis of Calcium Antagonists
    Figure 49. Calcium Antagonists Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India